In collaboration with the members of the Windsor Cancer Research Group (WCRG), ITOS is leading a multidisciplinary research study using blade cancer patient samples to identify a genetic signature that would predict the progression of cancer in these patients. ITOS is working on leading a clinical trial based on genomic profiling of myeloid malignancies from the University of Windsor as well as the Windsor Regional Cancer centre. ITOS has multiple international projects in sight as well.


Comments are closed.